Premium
Achieving better in‐hospital and after‐hospital care of patients with acute cardiac disease
Author(s) -
Scott Ian A,
Hickey Annabel C,
Sanders Daniela C J,
Jones Mark A,
Denaro Charles P,
Bennett Cameron J,
Mudge Alison M,
Thiele Justine M,
Flores Judy L,
Wenck Beres,
Bennett John W
Publication year - 2004
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2004.tb06076.x
Subject(s) - medicine , referral , psychological intervention , clinical pharmacy , community hospital , acute coronary syndrome , heart failure , pharmacist , emergency medicine , disease management , intensive care medicine , disease , myocardial infarction , pharmacy , nursing , parkinson's disease
In patients hospitalised with acute coronary syndromes (ACS) and congestive heart failure (CHF), evidence suggests opportunities for improving in‐hospital and after‐hospital care, patient self‐care, and hospital–community integration. A multidisciplinary quality improvement program was designed and instigated in Brisbane in October 2000 involving 250 clinicians at three teaching hospitals, 1080 general practitioners (GPs) from five Divisions of General Practice, 1594 patients with ACS and 904 patients with CHF. Quality improvement interventions were implemented over 17 months after a 6‐month baseline period and included: ➢ clinical decision support (clinical practice guidelines, reminders, checklists, clinical pathways); ➢ educational interventions (seminars, academic detailing); ➢ regular performance feedback; ➢ patient self‐management strategies; and ➢ hospital–community integration (discharge referral summaries; community pharmacist liaison; patient prompts to attend GPs). Using a before–after study design to assess program impact, significantly more program patients compared with historical controls received: ➢ ACS: Angiotensin‐converting enzyme (ACE) inhibitors and lipid‐lowering agents at discharge, aspirin and β‐blockers at 3 months after discharge, inpatient cardiac counselling, and referral to outpatient cardiac rehabilitation. ➢ CHF: Assessment for reversible precipitants, use of prophylaxis for deep‐venous thrombosis, β‐blockers at discharge, ACE inhibitors at 6 months after discharge, imaging of left ventricular function, and optimal management of blood pressure levels. Risk‐adjusted mortality rates at 6 and 12 months decreased, respectively, from 9.8% to 7.4% ( P = 0.06) and from 13.4% to 10.1% ( P = 0.06) for patients with ACS and from 22.8% to 15.2% ( P < 0.001) and from 32.8% to 22.4% ( P = 0.005) for patients with CHF. Quality improvement programs that feature multifaceted interventions across the continuum of care can change clinical culture, optimise care and improve clinical outcomes.